Posts Tagged ‘pharmaceutical’
Feds revive bill to build digitally connected health data systems for patients, providers
Thursday, February 5th, 2026
Canada’s health data system is “fragmented and siloed” and incomplete health records can compromise patient care and safety… If passed, the legislation would establish standards that companies developing electronic medical records must follow, allowing data to be shareable between health-care providers and across provinces and territories… “Canada’s diversity and single-payer model has created one of the most valuable health data sets on Earth,”
Tags: Health, jurisdiction, mental Health, pharmaceutical
Posted in Health Policy Context | No Comments »
Why drug approval in Canada should not rely on foreign regulators
Friday, January 30th, 2026
So far, there is no evidence to back up the claim that using decisions made by foreign drug regulators will lead to faster access to newer and better drugs. Before Canada proceeds down this pathway, Health Canada needs to show that it will improve public health.
Tags: Health, jurisdiction, pharmaceutical
Posted in Health Policy Context | No Comments »
4 things you need to know about health care in the federal budget
Monday, December 8th, 2025
Nearly $400 million in cuts to health… No plan to expand pharmacare… $5 billion for buildings – but no plan for health care workers… Cuts to refugee health care… “The affordability crisis is worsening, and Canadians need to know health care will be there when they need it most.
Tags: budget, Health, immigration, jurisdiction, pharmaceutical
Posted in Health Debates | No Comments »
Update the Canada Health Act
Monday, November 10th, 2025
After four decades, Canadians have a clearer sense of the system’s strengths and weaknesses. And the pandemic underscored both the value of universal health care and the urgent need for modernization… many changes could be achieved through more efficient organization, not just more spending. Nurse practitioners and physician assistants can often provide high-quality primary care less expensively than physicians, while expanded roles for pharmacists or midwives could also achieve savings and relieve some of the workload falling solely to family doctors.
Tags: economy, featured, Health, jurisdiction, pharmaceutical, standard of living
Posted in Health Debates | No Comments »
If a mine is a nation-building project, why not universal pharmacare? Inside the big push to get Mark Carney behind it
Monday, October 27th, 2025
The type of pharmacare most advocates want to see the policy evolve into is a universal, single-payer model, where governments would foot the majority of prescription drug costs for all Canadians… tens of billions of dollars Canada shells out on prescription medications annually would be better spent within the country’s borders, bolstering domestic production capacity… The gaps exposed by COVID-19 — the procurement chaos, supply chain woes, equipment shortages and expiring oversupply — make some believe pharmacare holds the potential to strengthen Canada’s autonomy and security, too.
Tags: budget, economy, featured, Health, ideology, jurisdiction, participation, pharmaceutical, standard of living
Posted in Health Debates | No Comments »
Health advocates call on Liberals to keep pharmacare promise ahead of budget
Tuesday, September 23rd, 2025
Health Minister Marjorie Michel and Carney’s office declined to commit to signing more pharmacare deals over the summer, and promised only to protect what was in place… The law requires the national drug agency to develop a list of essential drugs for a national formulary and to work on a national bulk-purchasing strategy to bring prices down.
Tags: budget, Health, pharmaceutical, privatization
Posted in Health Debates | No Comments »
Targeted Pharmacare Reforms Could Deliver Access Without a $40 Billion Price Tag
Thursday, September 18th, 2025
With 97 percent of Canadians already having access to some form of drug coverage, a new Conference Report by the C.D. Howe Institute finds that a fiscally responsible approach to universal pharmacare should focus on closing gaps in prescription drug coverage rather than replacing plans with a single-payer system.
Tags: budget, Health, participation, pharmaceutical, privatization
Posted in Health Debates | No Comments »
Mark Carney says he’ll make pharmacare deals with provinces, but won’t commit to expanding their coverage
Friday, September 12th, 2025
… “Ottawa has been dealing with a spate of new priorities since the beginning of the year, and [Dr. Eric Hoskins] understands why Carney is taking an “incremental” approach… the last thing anyone would have wanted is to create an even more patchwork program of diabetic medications and contraception, where you’ve got a handful of provinces and territories that have it, and others that don’t.”
Tags: budget, Health, jurisdiction, pharmaceutical, women
Posted in Health Policy Context | No Comments »
Ending vaccine mandates is a cynical political play – and it threatens children’s lives
Wednesday, September 10th, 2025
Only two jurisdictions – Ontario and New Brunswick – have legislated mandatory vaccine requirements for attendance at schools and daycares, but they allow medical, religious and philosophical exemptions. We make vaccine recommendations (which, for no good reason vary by province and territory) and expect parents to do the right thing for their own child and others.
Tags: Health, ideology, jurisdiction, participation, pharmaceutical, rights
Posted in Child & Family Policy Context | No Comments »
How Donald Trump’s tariffs threaten Canadians’ access to prescription drugs
Friday, May 9th, 2025
Thirty-two per cent of the active pharmaceutical ingredients that go into the medicines that North Americans take originate in China. U.S President Donald Trump has now threatened to slap U.S. tariffs on Chinese drugs and drug ingredients that were previously exempt… Canada already imports $8.76 billion annually in prescription drugs from the U.S. To the extent that tariffed drugs go from China to the U.S. to Canada, the cost of both publicly and privately funded drug plans will increase.
Tags: budget, economy, featured, Health, pharmaceutical
Posted in Health Debates | No Comments »
Recent Comments